Abstract:Objective: To compare executive function and attention of patients with schizophrenia, their siblings, and healthy controls. Patients and Methods: The Wisconsin Card Sorting Test and Continuous Performance Test were administered to 50 patients with schizophrenia, 50 unaffected siblings of patients with schizophrenia, and 45 healthy controls. Results: Patients and their siblings performed worse than the healthy controls in the Wisconsin Card Sorting Test (p Conclusion: The results support not only that patients with schizophrenia have attention and executive function impairments, but also their unaffected siblings have some cognitive function impairments. Key words: Attention, Cognitive function, Schizophrenia, Siblings Introduction The symptoms of schizophrenia can be divided into 4 dimensions: positive symptoms, negative symptoms, cognitive deficits, and affective symptoms. (1) Although cognitive deficits have not yet been included in the diagnostic criteria of schizophrenia, they are one of the important core manifestations of this disorder and provide important diagnostic information, both in the phenotypic and prodromal phases. In addition, they may also lead to new clues to the treatment of this disorder. Genetics is an important aspect in the study of schizophrenia. With the use of neuropsychological testing instruments, the phenotype of the cognitive deficits of patients with this disorder, which is regarded as independent of positive and negative symptoms, may be investigated. (2,3) The results of previous studies indicate that the siblings of patients with schizophrenia possess similar cognitive deficits to those manifested in patients with schizophrenia. (4-6) However, there has been little research in this area in Chinese people. In this study, attention and executive function of patients with schizophrenia, their siblings, and healthy controls were investigated. It is hypothesised that both the patients with schizophrenia and their siblings manifest cognitive deficits compared to normal controls. Patients and Methods Participants There were 3 groups of participants, as shown below. All participants were interviewed by 2 psychiatrist investigators who made the diagnoses. Group 1 comprised 50 patients with schizophrenia recruited from the inpatient and outpatient units of the Department of Psychiatry of the Second Xingya Hospital of Central South University in Changsha, China. The inclusion criteria were as follows: * patients met the diagnostic criteria of schizophrenia or schizophreniform disorder described in DSM-IV * age within 18 to 50 years * no history of receiving electroconvulsive therapy * no chronic neurological disorders or severe medical disorders * no history of alcohol- or substance-abuse * no colour blindness. All patients were taking antipsychotic medication, with 22 taking clozapine and 28 taking risperidone. The illness duration of the patients varied from 1 to 375 months (median, 5 months). Group 2 comprised 50 siblings of patients with schizophrenia, with 1 sibling from each family of 1 patient with schizophrenia. The inclusion criteria were the same as for group 1 except that they were not required to meet the diagnostic criteria of any psychiatric disorders. Each participant and his/her corresponding sibling with schizophrenia had the same biological parents. Group 3 comprised 45 healthy controls, who were physicians, nurses, or employees from the Second Xingya Hospital. …

Change in IQ in Schizophrenia Patients and Their Siblings: a Controlled Longitudinal Study

Is There Change in Intelligence Quotient in Chronically Ill Schizophrenia Patients? A Longitudinal Study in Twins Discordant for Schizophrenia.

Brain Abnormalities And Iq In Offspring, Siblings, Co-Twins, And Parents Of Patients With Schizophrenia

IQ change over time in schizophrenia and healthy individuals: a meta-analysis.

Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia.

Cognitive Functioning Throughout Adulthood and Illness Stages in Individuals with Psychotic Disorders and Their Unaffected Siblings

Association of IQ Changes and Progressive Brain Changes in Patients with Schizophrenia

Neuropsychological Dysfunctions in Siblings Discordant for Schizophrenia

Educational achievement in psychiatric patients and their siblings: a register-based study in 30 000 individuals in The Netherlands.

Attention and Executive Function Impairments in Unaffected Siblings of Patients with Schizophrenia

Risk of adult schizophrenia and its relationship to childhood IQ in the 1958 British birth cohort

F17. DIFFERENCES IN INTRACRANIAL VOLUME, IQ AND PSYCHOPATHOLOGY IN YOUNG OFFSPRING OF PATIENTS AFFECTED WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

A Five- to Fifteen-Year Follow-up Study of Infantile Psychosis

The comparative study of cognitive functions between familial and sporadic patients with first-episode schizophrenia

Heritability of Verbal and Performance Intelligence in A Pediatric Longitudinal Sample

Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls

Global Intellectual Impairment Does Not Accelerate with Age in Patients with Schizophrenia: a Cross-Sectional Analysis.

Deviation from Expected Cognitive Ability Across Psychotic Disorders

Association of schizophrenia polygenic risk score with data-driven cognitive subtypes: A six-year longitudinal study in patients, siblings and controls

Intelligence, educational attainment, and brain structure in those at familial high‐risk for schizophrenia or bipolar disorder

Brain developmental trajectories in offspring of parents with schizophrenia or bipolar disorder